Korea Meeting Vows To Support Global Infectious Disease Fight
This article was originally published in PharmAsia News
Delegations from 47 countries and nine international organizations gathered in Seoul recently for the second Global Health Security Agenda (GHSA) High-Level Meeting, where South Korea vowed to provide $100m to 13 developing countries over the next five years to help them deal with infectious diseases. The “Seoul Declaration” adopted after the meeting presented 11 global health security action packages and specific targets.
You may also be interested in...
GemVax unveils positive topline results for South Korean Phase II study of novel peptide drug targeting patients with moderate to severe Alzheimer’s disease, raising hopes for the upcoming US trials.
Daewoong Pharmaceutical has successfully completed a Phase III clinical trial of next generation gastroesophageal reflux disease (GERD) drug candidate in South Korea, but strong competition awaits from approved P-CAB drugs of CJ Healthcare and Takeda.
Novel antifungal T-2307, discovered by FUJIFILM Toyama, works by selectively disrupting mitochondrial function. Excelra and Maruho team up to repurpose existing drugs.